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Abstract 19 
Pharmaceutical contamination of the environment is recognized as a global problem although 20 
work has focused on Europe and North America to date and there remains a dearth of 21 
information for developing countries, including those in Africa. To address this data gap the 22 
occurrence of thirty-seven pharmaceuticals belonging to nineteen therapeutic classes was 23 
monitored in surface water and effluent in Lagos State, Southwest Nigeria. Samples were 24 
collected quarterly from twenty-two sites and twenty-six compounds were detected at least 25 
once, many in the micrograms per litre range. Maximum concentrations for those compounds 26 
detected ranged from 75 to 129 µg L-1 and even mean concentrations for thirteen compounds 27 
were in the order of µg L-1. These values are amongst the highest ever measured globally.  28 
Sewage effluent was more important than drug manufacturing waste in polluting rivers 29 
although there are likely to be numerous unregulated sources of effluent being discharged to 30 
rivers which require further study, including urban waste collection areas and vacuum trucks 31 
which collect effluent. Seasonal trends in the data were complex with some compounds being 32 
found at higher concentrations in the dry season and, conversely, others being greater during 33 
the wet period, this variation potentially relating to the variety of pollution sources in the 34 
catchment. Pharmaceuticals are indispensable to human health although their usage and 35 
discharge into the aquatic environment may lead to ecological problems and antibiotic 36 
resistance. The data presented in this paper indicate that pharmaceutical pollution of 37 
freshwaters is a serious issue in Nigeria and management efforts are needed to ameliorate this 38 
issue. 39 




   
 
1. Introduction  44 
Pharmaceuticals were first detected in the environment in the 1970’s (Tabak and Bunch, 45 
1970; Norpoth et al., 1973) and since then numerous studies have quantified their occurrence 46 
in aquatic systems. The majority of these studies have been undertaken in Europe and North 47 
America (Hughes et al., 2013) whilst far fewer have been performed in low to medium 48 
income countries, including those in Africa, South America and the Middle East (Hughes et 49 
al., 2013). A small number of studies have been undertaken in Africa and detection 50 
frequencies have been high at between 60 and 100 % (Ngumba et al., 2016) with 51 
concentrations typically greater than those measured in the West (Fekadu et al., 2019). In 52 
Kenya concentrations of up to 167 µg L-1 were found in sewage effluent and surface waters 53 
(K’Oreje et al., 2012, 2016, 2018) whilst in South Africa pharmaceuticals have also been 54 
found to be ubiquitous in effluent and freshwaters at concentrations ranging from ng L-1 to µg 55 
L-1 (Agunbiade and Moodley, 2015; Gumbi et al., 2017). Such high concentrations may be 56 
due to a number of factors including high drug usage and poor regulation of this, the presence 57 
of numerous pharmaceutical manufacturing plants, and poorly developed sewage treatment 58 
facilities (Fekadu et al., 2019). In Nigeria, analgesics, antibiotics, antacids, antihistamines, 59 
anticonvulsants, steroids, antimalarials and antihypertensives are among the most consumed 60 
classes of drugs and are routinely purchased without a prescription (Odunsanya, 2005). 61 
However, the statistics available on the usage of pharmaceuticals are not reliable because of 62 
the activities of unregistered pharmacies in some cities such as Lagos (Akande and Ologe, 63 
2007; Oshikoya and Ojo, 2007; Nwolisa et al., 2006; Odunsanya, 2005). The current paper 64 
aims to add to the limited occurrence data for pharamceuticals in African effluent and surface 65 
water and, therefore, improve our understanding of the global importance of pharamceutical 66 
pollution. We report the results of a monitoring campaign to understand the occurrence of 67 
thirty-seven pharmaceuticals in the Odo-Iya Alaro River catchment in Lagos, Nigeria, a 68 
   
 
country where few pharmaceutical monitoring data are available. The main objectives were: 69 
(i) to understand the extent to which drugs belonging to different therapeutic classes are 70 
found in effluents and surface water, (ii) to quantify spatial and temporal patterns of 71 
pharmaceutical contamination and, (iii) to highlight particular compounds of environmental 72 
concern. 73 
 74 
2. Methods 75 
2.1. Substances monitored 76 
The pharmaceuticals monitored (Table 1) were chosen based on their expected presence in 77 
surface waters (Burn et al., 2018), being high-use drugs that have been found previously in 78 
rivers around the world (Hughes et al., 2013). 79 
 80 
2.2. Study catchment 81 
The Odo-Iya Alaro River (Figure 1) forms a sub-catchment of the Ogudu river, which 82 
discharges into the Lagos lagoon, and flows through Ogba, Ikeja and Maryland which have a 83 
combined population of 2.5 million people. The catchment contains a sewage treatment plant 84 
(STP), three major pharmaceutical manufacturing plants and many smaller ones located in 85 
the industrial estates of Ogba and Ikeja which discharge their effluents through drainage 86 
pipes and canals into the river. Some of these canals pass through densely populated urban 87 
areas which discharge untreated domestic waste to them and raw sewage may also enter the 88 
river due to emptying of vacuum trucks which collect untreated effluent in urban areas 89 
(Ogunbanwo, 2011). Twenty-two sampling stations were located along the river based on 90 
accessibility and the potential to sample both receiving waters and effluents being discharged 91 
to them (Table S1).  92 





Table 1. Physico-chemical properties of the pharmaceutical compounds monitored in the Odo Iya Alaro river, Lagos, Nigeria 
(www.drugbank.ca) 
 
Therapeutic Group Compound LogKow pKa Molecular Wgt (g ml-1) Formula Solubility (mg L-
1) 
Analgesic & Anti-inflammatory Codeine 1.19 8.21- 10.60 299.37 C18H21NO3  9000 
 Hydrocodone 2.16 8.23 299.37 C18H21NO3  n/a 
 Paracetamol 0.46-0.49 9.38 151.17 C8H9NO2 14000 
 Tramadol 3.01 9.41 263.38 C16H25NO2 630 
Antacid Cimetidine 0.40 6.80 252.34 C10H16N6S 9380 
 Ranitidine 0.27 8.08 314.40 C13H22N4O3S 24700 
Antiallergic Loratadine 5.20 5.00 382.89 C22H23CIN2O2 0.011 
Antibiotics Erythromycin 3.06 8.88-8.90 733.94 C37H67NO13 2000 
 Sulfamethoxazole 0.89 1.60-5.70 253.28 C10H11N3O3S 610 
 Trimethoprim 0.91 7.12 290.32 C14H18N4O3 400 
Anticonvulsant Carbamazepine 2.45 13.90 236.27 C15H12N2O 17.7 
 Gabapentin         -1.10 3.68-10.70 171.24 C9H17NO2 4490 
Antidepressant Amitriptyline 4.92 9.40-9.76 277.41 C20H23N 9.71 
 Desvenlafaxine 2.72 10.11 263.38 C16H25NO2 1400 
 Diltiazem 2.7 8.06 414.52 C22H26N2O4S 465 
 Oxazepam 2.24 10.90 286.72 C15H11CIN2O2 179 
 Venlafaxine 3.20 10.09 277.41 C17H27NO2 267 
Antihistamine Diphenhydramine 3.27 8.98 255.36 C17H21NO 3060 
 Fexofenadine 2.81 4.28-8.76 501.67 C32H39NO4 0.024 
 Ketotifen 3.85 8.43 309.43 C19H19NOS 15.3 
 Ceterizine 1.70-3.57 3.58-7.74 388.89 C21H25CIN2O3 65.8 
Antidiabetic Metformin -2.64 12.40 165.63 C4H12CIN5 n/a 
 Sitagliptin 1.39 8.78 407.32 C16H15F6N5O 179.2 
Antipsychotic Diazepam 2.82 3.40 284.74 C16H13CIN2O 50 
 Temazepam n/a -1.4-10.68 300.74 C16H13CIN2O2 164 
Anti-malaria Artemisinin 2.90 4.60 282.22 C15H22O5 n/a 
Antiarrhythmic Lidocaine 2.26 8.01 234.34 C14H22N2O 4100 
Antiretroviral Lamivudine -9.54 -0.16-14.29 229.25 C8H11N3O3S 70000 
Antiviral Oseltamivir 0.95 7.70 312.41 C16H28N2O4 1600 
Contraceptive Norethisterone 2.97 -1.7-17.59 298.43 C20H26O2 7.04 
Beta Blocker Atenolol 0.16 9.60 266.34 C14H22N2O3 13300 




 Propranolol -0.45 9.42 259.35 C16H21NO2 61.7 
SERM Raloxifene 6.09 7.99-9.92 473.59 C28H27NO4S 0.25 
Diuretics Triamterene 0.98 3.11-15.88 253.27 C12H11N7 48.2 
Calcium-Channel Blocker Verapamil 3.83 8.92 454.61 C27H38N2O4 4.47 
SSRIs Sertraline 4.30 9.47 306.23 C17H17CI2N 3.5 
 Citalopram 1.39 9.50 324.40 C20H21FN20 n/a 
n/a = not available; Wgt =Weight       
 94 




       95 
Figure 1. The Odo-Iya Alaro river in Lagos State, Southwest Nigeria and the twenty-two sampling stations used in the current study.  96 
              97 
         98 




2.3. Sample collection 99 
Effluent and surface water samples were collected on a quarterly basis to incorporate both the 100 
wet (April and July) and dry seasons (October and January). Amber glass sampling vessels 101 
were rinsed with 100% methanol once and deionised water three times to remove potential 102 
contamination before sampling. Samples were collected at the same time of day and location, 103 
checked using a Global Positioning System (GPS). At each sampling site, three 50 mL water 104 
samples were collected and then homogenised into a single 150 mL composite sample. A 10 105 
mL aliquot of each composite sample was then filtered on site through a Whatman GFF (0.7 106 
µm pore size) glass microfiber syringe filter into a 20 mL amber glass vial with a Teflon-107 
lined screw cap (Fisher Scientific, UK). Samples were frozen immediately with dry ice 108 
before shipping within 24 hrs to the UK for analysis. On arrival (three days), samples were 109 
thawed immediately and analysed.  110 
2.4 Chemical analysis 111 
Quantification of pharmaceutical concentrations was achieved using HPLC-MS/MS with a 112 
Thermo Scientific TSQ Endura Mass spectrometer coupled with an UltiMate 3000 liquid 113 
chromatograph. The method used was adapted from Furlong et al. (2014) and further 114 
validated (Burns et al., 2018). Briefly, prior to starting the quantitative analysis, 500 µL of 115 
each water sample was diluted with 495 µL of HPLC-grade water and spiked with 5 µL of a 116 
mixture of internal standards (each at a concentration of 80 µg L-1) in glass autosampler vials. 117 
The 50 % dilution was done in order to clean the samples and bring analyte concentrations to 118 
within the calibrated range. Where concentrations were found to still exceed the calibrated 119 
range further dilution and reanalysis was carried out. A random number generator was used 120 
to randomise the order in which samples were injected onto the HPLC-MS/MS. Analysis was 121 
conducted by direct injection of 100 µL of each sample into a Phenomenex Eclipse Plus C18 122 
chromatography column using a Phenomenex C18 (ODS, Octadecyl) 4 mm x 3 mm ID guard 123 




column. Mobile phase A was HPLC-grade water with 0.01 M formic acid and 0.01 M 124 
ammonium formate while mobile phase B was 100 % HPLC-grade methanol. A flow rate of 125 
0.45 mL min-1 was used with a gradient starting at 10 % B which then increased to 40 % at 5 126 
min, 60 % at 10 min, 100 % at 15 min, and remaining 100 % B until 23 min then dropping to 127 
10 % at 23 min prior to a re-equilibration. The autosampler temperature was kept at 4C and 128 
the HPLC column compartment at 40C. The collision gas was argon at a pressure of 2 129 
mTorr. Quantification was done with a 16-point calibration using deuterated internal 130 
standards (Burns et al., 2018) ranging from 1 to 32000 ng L-1 and calibration r2-values were 131 
consistently >0.95. Analytical limits of detection were calculated as described by Burns et al. 132 
(2018) and ranged from 0.9 ng L -1 (carbamazepine) to 12.4 ng L-1 (gabapentin) (Table S2). 133 
Quality control (QC) measures were used throughout the analysis; briefly, method blanks 134 
(n=6) were made with an identical collection procedure as the environmental samples 135 
although using HPLC-grade water. Concentrations of the target pharmaceuticals were 136 
consistently below levels of analytical quantification in the method blanks. Additionally, QCs 137 
consisting of all target pharmaceuticals at a concentration of 80 ngL-1 were injected after 138 
every 4 samples followed by an instrumental blank consisting of pure HPLC-grade water. 139 
Analytical tolerance was consistently within ±15 % and the instrumental blanks did not 140 
contain detectable residues of the target analytes.  141 
2.5 Data analysis 142 
Data were organised using Excel (Microsoft, 2013) and residuals of the data were checked 143 
for normal distribution using the Shapiro-Wilk normality test and homogeneity of variance 144 
using the Bartlett test of homogeneity of variances. R (R Development Core Team, 2008) 145 
was used to analyse the data; general linear model and Chi-square were used to find if there 146 
were differences between the sampling sites. Seasonal variations were analysed using one-147 
way ANOVA where assumptions of normality and homogeneity were met followed by 148 




Tukey’s post-hoc tests to determine if there is any variation in concentrations between the 149 
wet and the dry the seasons. 150 
 151 
3. Results  152 
3.1 Detection frequencies 153 
All of the study compounds were detected although the frequency of detection varied greatly 154 
for different substances (Figure 2). Some, including carbamezapine, fexofenadine and 155 
paracetamol, were present in sewage effluent and surface waters most of the time whereas 156 
others, such as diltiazem, propranolol and venlafaxine, were rarely detected. Detection 157 
frequencies in pharmaceutical manufacturing effluent were significantly lower than in 158 






















































































































































































Figure 2. Detection frequencies for pharamceuticals measured in sewage effluent, 161 
pharmaceutical manufacturing waste and rivers (urban and semi-urban). 162 
   163 




3.2 Pharmaceutical concentrations 164 
Peak pharmaceutical concentrations were in the range of hundreds of micrograms per litre 165 
while mean concentrations were several orders of magnitude lower (Figure 3). The antibiotic 166 
sulfamethoxazole was detected at the highest concentration of 129.4 µg L-1 whilst 167 
paracetamol was also measured at 111.4 µg L-1. Paracetamol and sulfamethoxazole also had 168 
the highest mean concentrations of 18.2 and 11.2 µg L-1 respectively. Many other compounds 169 
were found at concentrations only slightly lower than these including cimetidine, 170 
fexofenadine, carbamazepine, metformin, diazepam, atenolol, trimethoprim, and codeine 171 
(Table S3).  172 


























Figure 3. Pharmaceutical concentrations measured in the Odo Iya Alaro river catchment, 174 
Lagos, Nigeria. Boxes represent median and 25th and 75th percentiles whilst whiskers show 175 
minimum and maximum values. 176 
 177 




There was a significant difference in pharmaceutical concentrations in the different matrices 178 
sampled (GLM: χ2 (3) = 883.32, p <0.001). When pharmaceuticals were detected in 179 
manufacturing effluent concentrations tended to be higher than in sewage effluent and river 180 
water. Drugs were diluted slightly after sewage effluent had entered urban rivers although 181 
concentrations were lower still in semi-urban reaches. Although detection frequencies were 182 















































Figure 4. Comparison of pharmaceutical concentrations measured in the wet and dry seasons 186 
in different matrices in the Odo Iya Alaro river, Lagos, Nigeria. SEW = sewage effluent in 187 
wet season, SED = sewage effluent in dry season, PEW = pharmaceutical manufacturing 188 
effluent in wet season, PED = pharmaceutical manufacturing effluent in dry season, URW = 189 
urban river in wet season, URD = urban river in dry season, SURW = sub-urban river in wet 190 
season, SURD = sub-urban river in dry season. Boxes represent median and 25th and 75th 191 
percentiles whilst whiskers show minimum and maximum values. 192 





4. Discussion 194 
 195 
Pharmaceuticals are biologically active and pseudo-persistent in the environment due to the 196 
continual input of wastewater effluent to rivers (Hughes et al., 2013; Kay et al., 2017; Burns 197 
et al., 2018) and, therefore, potentially pose a toxicological risk to non-target organisms 198 
(Boxall et al., 2002; Huang et al., 2012). Monitoring has mainly taken place in Europe and 199 
the United States though and data are severely lacking for developing countries, such as those 200 
in Africa. This paper addresses this important research gap by presenting new information 201 
about the presence of pharmaceuticals in pharmaceutical manufacturing effluent, sewage 202 
effluent and surface water in Lagos, Nigeria, a country which has been studied very little.  203 
The detection of twenty-six pharmaceuticals in the Odo Iya Alaro river confirmed the 204 
presence of these substances in Nigerian watercourses including some that have not 205 
previously been observed in African rivers more widely. These were from a wide range of 206 
therapeutic classes including anti-inflammatories, antidepressants and antihistamines, and 207 
were present at relatively high concentrations compared to some other drugs that were 208 
measured. Pseudo-persistence was observed, presumably due to continuous discharge of 209 
effluents to the river, similar to that found in other studies. One of the key findings of the 210 
current study is that pharmaceutical concentrations in the environment are often two to three 211 
orders of magnitude higher than typically reported in Europe and the US where most 212 
monitoring has been undertaken (Verlicchi et al. 2012; Hughes et al., 2013; Aus der Beek et 213 
al., 2016; Madikizela et al., 2017; Burns et al., 2018). Some of the highest pharmaceutical 214 
concentrations ever found in rivers globally have been reported in this paper, it not being 215 
uncommon to have measured levels in the tens of micrograms per litre range up to 129 µg L-216 
1. This is in-line with findings in Kenya ((K’Oreje et al., 2012, 2016, 2018). Particular 217 
compounds of concern in the Nigerian environment appear to be carbamezapine, cimetidine, 218 
fexofenadine, metformin, paracetamol and sulfamethoxazole. The presence of a range of 219 




substances at such high concentrations may be attributed to a range of factors including over-220 
the-counter sales, differences in health issues, poorer removal efficiencies at wastewater 221 
treatment plants, unregulated discharges by pharmaceutical manufacturing companies, and 222 
illegal disposal of sewage by vacuum trucks. Other workers have proposed that these sources 223 
are likely to be important in Africa (Fekadu et al., 2019) and further study is needed to 224 
disentangle inputs from these various sources. 225 
There were few spatial trends observed in pharmaceutical pollution in this study which 226 
appears to be ubiquitous although the absence of many compounds in pharmaceutical 227 
production effluent suggests that sewage effluent is the main source of pollution. Indeed, the 228 
occurrence and concentrations of pharmaceuticals in wastewater treatment plant effluent and 229 
surface water were very similar. This highlights that receiving waters have little capacity to 230 
dilute effluent but also that further unregulated and unmonitored sources of effluent may be 231 
discharging to the river, such as vacuum trucks collecting effluent in urban areas. Other work 232 
in India has however proposed that pharmaceutical production facilities are a key source of 233 
pharmaceutical pollution developing countries (Balakrishna et al., 2017). 234 
Although season had an impact on pharmaceutical pollution a complex picture exists with 235 
some compounds being found at extremely high concentrations in the dry season and, 236 
conversely, others being relatively high during the wet season. Previous studies have 237 
proposed a range of reasons for variation across the year, including seasonal usage and 238 
changes in environmental conditions (e.g. temperature and river flow) (Tewari et al., 2013; 239 
Kolpin et al., 2014; Fekadu et al., 2019). It may be that the multiple sources of 240 
pharmaceuticals in the catchment results in the complexity of spatial patterns found in the 241 
current study, with some continuous effluent discharges being diluted in the wet season but 242 
other sources (e.g. urban waste sites) having pollutants mobilised in periods of rainfall. 243 




5. Conclusion 244 
This is the most detailed study to date of pharmaceutical pollution in African river 245 
catchments and it has highlighted their occurrence at some of the highest concentrations ever 246 
found globally. Concentrations in Nigerian rivers appear to be several orders of magnitude 247 
higher than those reported for Europe and the US and, in some cases, even higher than the 248 
few existing values produced for other developing countries. Sewage effluent appears to be 249 
the key source of pollution although it is speculated that further investigation of unregulated 250 
sources is needed. Whilst also important, it appears that many compounds are not discharged 251 
from drug manufacturing plants. The complexity of temporal patterns across seasons is 252 
proposed to be due to a greater range of sources contributing to pharmaceutical loads than in 253 
many existing studies, which poses a particular research challenge for understanding and 254 
managing pharmaceutical pollution in African rivers. The scenario presented here has a 255 
strong likelihood of being replicated in other major African cities as well as megacities in 256 
other developing nations globally, where pharmaceuticals are available over the counter and 257 
where wastewater discharges to rivers proceed without regulation. A key implication for the 258 
global research agenda on pharmaceutical occurrence, fate and effects is that studies should 259 
focus more on developing countries where contamination of water is likely to be most 260 
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